DROPERIDOL AJS droperidol 2.5 mg/1 mL solution for injection glass ampoule

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

droperidol, Quantity: 2.5 mg

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Droperidol

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: mannitol; tartaric acid; sodium hydroxide; water for injections

Administration route:

Intravenous, Intramuscular

Units in package:

10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Anaesthesia Droperidol AJS Injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia in neuroleptanalgesia in which Droperidol AJS Injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,Psychiatry The management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

Product summary:

Visual Identification: DROPERIDOL 2.5 mg/ml solution for injection is a sterile liquid in brown 1mL glass ampoules containing 2.5 mg Droperidol.; Container Type: Ampoule; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2017-03-06